Coulter Partners

About Us

We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.

Achievements

Recent Placements

Coulter Partners

Find a Recruiter

0

The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.

Our Team

Coulter Partners

Solutions And Expertise

Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database.  Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.

Solutions
  • Advisory Services
  • Assessment
  • Board Services
  • Culture Shaping
  • Data Analy./Mrkt. Intell.
  • Diversity & Inclusion
  • Executive Coaching
  • Executive Search
  • Leadership Consulting
  • Leadership Develop.
  • Mgmt. Consulting
  • Onboarding
  • Recruitment Research
  • Succession Planning
Industries
  • Agriculture
  • Biotechnology
  • Chemicals
  • Clean Tech./Sustain.
  • Clinical Research
  • Consulting
  • Consumer
  • Consumer Products
  • Consumer Services
  • Data & Analytics
  • Devices
  • Energy
  • Family Offices
  • Financial Services
  • FinTech
  • Foundations
  • Healthcare Services
  • High Tech
  • Industrial
  • Industrial Products
  • Internet
  • Life Sci./Healthcare
  • Machine Learning
  • Medical
  • Medical Devices
  • Natural Resources
  • Non-Profit
  • Pharmaceuticals
  • Private Equity
  • Professional Services
  • Software
  • Supply Chain
  • Technology
  • Venture Capital
Functions
  • Board/Governance
  • Business Development
  • CEO/President
  • Data/Analytics
  • Diversity & Inclusion
  • Finance/Accounting
  • General Management
  • GM/Operations
  • Human Resources
  • Information/Digital
  • Investor Relations
  • Legal/Compliance
  • Manufacturing
  • Marketing & Sales
  • Medical/Clinical
  • Research & Develop.
  • Supply Chain

Coulter Partners

News Briefings

Coulter Partners Lands New CEO for Stevenage Bioscience Catalyst
 Coulter Partners Sally Ann Forsyth CEO Stevenage Bioscience Catalyst

Executive search firm Coulter Partners has placed Sally Ann Forsyth as the new CEO of Stevenage Bioscience Catalyst (SBC). She assumes her new role in March. Dr. Forsyth, who is known for her scientific and financial expertise and as an open innovation practitioner, will lead SBC through its next phase of expansion. “Everyone talks about board and sector

Coulter Partners Finds Chair for Cell Medica
 Coulter Partners Annalisa Jenkins chair Cell Medica

Executive search firm Coulter Partners has placed Annalisa Jenkins as chair for Cell Medica, a leader in next generation cellular immunotherapies for the treatment of cancer. “Everyone talks about board and sector leadership diversity – here we see another excellent female chair appointed and are proud to have been involved in this transatlantic search,” said Bianca Coulter,

Coulter Partners Completes Searches for Cambridge Epigenetix
 Coulter Partners Cambridge Epigenetix Hayden Jeffreys COO Joanne Mason VP

Executive search firm Coulter Partners recently helped Cambridge Epigenetix (CEGX), a pioneer in the development and application of epigenetic technologies, to secure the appointment of two diagnostic experts. Hayden Jeffreys joins the company as chief operating officer and Dr. Joanne Mason becomes vice president of biomarker discovery. The appointments are designed to further strengthen CEGX’s in-house expertise

Coulter Partners Expands As Life Sciences Sector Booms

Global life sciences recruiter Coulter Partners has made seven new appointments in the U.S., Switzerland, Germany and at its London headquarters. Joining the firm are Nona Footz, client partner; Samantha Simonnet, director on the U.S. West Coast; Jean Kim, associate director in New York; and Marie-Garance Leroy, senior consultant in Zurich. Also, Samantha Ng was appointed senior

Coulter Partners

Press Releases

Coulter Partners Secures Chief Finance Officer and Non- Executive Director for Optimapharm

(March 1, 2021) Coulter Partners was delighted to partner again recently with Optimapharm to secure the appointments of Walter Miller as Chief Finance Officer and Dr Charles Woler, M.D., Ph.D., as Non-Executive Director. Optimapharm is a contract research organization (CRO) managing clinical trials on behalf of leading biotech, pharma and medical devices companies in 27

Coulter Partners secures Chief Financial Officer for Saniona

(Aug. 27, 2020) Coulter Partners was very pleased to partner once again with Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, to secure the appointment of Jason A. Amello as Chief Financial Officer. Jason will be based in the U.S. and will support Saniona’s advancement of late-stage clinical trials with lead

Coulter Partners Secures Chief Medical Officer for Sequana Medical

(Aug. 20, 2020) Coulter Partners was very pleased to partner recently with Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, to secure the appointment of Oliver Gödje, MD, PhD, as Chief Medical Officer. Dr Gödje replaces Gijs Klarenbeek, MD, who remains

Coulter Partners Secures Chief Executive Officer for Optimapharm

(July 28, 2020) Coulter Partners was delighted to partner recently with Optimapharm to secure the appointment of Dr. Andrew Copestake as Chief Executive Officer. Andrew joins Optimapharm’s executive management team following several months advising the company’s Board of Directors. Optimapharm is a contract research organization managing clinical trials on behalf of leading biotech, pharma and

Coulter Partners Secures Supervisory Board Directors for Pharming Group

(June 20, 2020) Coulter Partners was delighted to partner recently with Pharming Group N.V. (Euronext Amsterdam: PHARM), to secure the nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors. An Extraordinary General Meeting of Shareholders is expected to be convened later this year for their official appointment. Until that moment, Barbara